News
- 2018/11/15
- On November 15, 2018, our popular anti-human SF-1 antibody was relaunched as Protein A-purified grade.
- 2018/03/30
- PPMX received 1.4 billion yen from Nippon Venture Capital Co.,Ltd. and other capitals in a third party allocation of shares.
- 2016/01/12
- Fujifilm initiates a Phase I clinical trial of the anti-cancer agent “FF-21101” (RI labeled antibody) in the United States. PPMX contributed to creating antibody based on antibody engineering technology.
- 2014/12/18
- PPMX receives JST Grant to develop Anti TfR antibody for Adult T-cell Leukemia.
